Cargando…

Targeting the Brain to Protect the Heart

[Figure: see text]

Detalles Bibliográficos
Autor principal:	Lopaschuk, Gary D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Preclinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838095/ https://www.ncbi.nlm.nih.gov/pubmed/33533757 http://dx.doi.org/10.1016/j.jacbts.2020.12.004

Ejemplares similares

Discovery of a Small Molecule to Increase Cardiomyocytes and Protect the Heart After Ischemic Injury
por: Hara, Hironori, et al.
Publicado: (2018)

Adaptive Reductions in Left Ventricular Diastolic Compliance Protect the Heart From Stretch-Induced Stunning
por: Weil, Brian R., et al.
Publicado: (2019)

Targeting Calpain for Heart Failure Therapy: Implications From Multiple Murine Models
por: Wang, Yihui, et al.
Publicado: (2018)

Malonyl CoA Decarboxylase Inhibition Improves Cardiac Function Post-Myocardial Infarction
por: Wang, Wei, et al.
Publicado: (2019)

Epigenetic Regulation of Heart-ECHS
por: Gan, Lu, et al.
Publicado: (2022)

Resolution of Heart Failure Inflammation
por: Bäck, Magnus
Publicado: (2022)

In Situ Heart Valve Tissue Engineering: Is Scaffold Structural Biomimicry Overrated?
por: Mela, Petra, et al.
Publicado: (2020)

A Novel Inducer of Autophagy in the Heart
por: Mukai, Risa, et al.
Publicado: (2021)

Protein Kinase C Inhibition With Ruboxistaurin Increases Contractility and Reduces Heart Size in a Swine Model of Heart Failure With Reduced Ejection Fraction
por: Sharp, Thomas E., et al.
Publicado: (2017)

Targeting Syntaxin 17 to Improve Mitophagy in Heart Failure
por: Forte, Maurizio, et al.
Publicado: (2023)

Hypoxia as a target for drug combination therapy of liver cancer
por: Bowyer, Cressida, et al.
Publicado: (2017)

Novel Mechanistic Roles for Ankyrin-G in Cardiac Remodeling and Heart Failure
por: Makara, Michael A., et al.
Publicado: (2018)

Glucagon Receptor Antagonism Ameliorates Progression of Heart Failure
por: Gao, Chen, et al.
Publicado: (2019)

PECUU-ECM Patches: The Future of Ischemic Heart Disease Repair
por: Ajaj, Yasmeen, et al.
Publicado: (2021)

Phosphorylation of Hsp20 Promotes Fibrotic Remodeling and Heart Failure
por: Gardner, George T., et al.
Publicado: (2019)

Potential of AT(1)-R-Biased Agonists in Pediatric Heart Failure
por: Port, J. David
Publicado: (2020)

Location-specific and Kinase-Independent GRK5 Function in Heart
por: Wang, Yifan F., et al.
Publicado: (2022)

Renal Dysfunction in Heart Failure: The Role of Cardiac Afferent Fibers
por: Hadaya, Joseph, et al.
Publicado: (2022)

Cardiac GRK2 and the Communicative Axis Between Heart and Fat
por: Hill, Bradford G.
Publicado: (2022)

Cardiac Mesenchymal Stem Cells Promote Fibrosis and Remodeling in Heart Failure: Role of PDGF Signaling
por: Hamid, Tariq, et al.
Publicado: (2022)

A Novel Biological Strategy for Myocardial Protection by Intracoronary Delivery of Mitochondria: Safety and Efficacy
por: Shin, Borami, et al.
Publicado: (2019)

The Effect of Estrogen on Intracellular Ca(2+) and Na(+) Regulation in Heart Failure
por: Firth, Jahn M., et al.
Publicado: (2020)

Heart Failure With Reduced Ejection Fraction Is Characterized by Systemic NEP Downregulation
por: Pavo, Imre J., et al.
Publicado: (2020)

Seipin Knockout Mice Develop Heart Failure With Preserved Ejection Fraction
por: Bai, Bo, et al.
Publicado: (2019)

Development of Tissue Engineered Heart Valves for Percutaneous Transcatheter Delivery in a Fetal Ovine Model
por: Zakko, Jason, et al.
Publicado: (2020)

Systems Analysis Implicates WAVE2 Complex in the Pathogenesis of Developmental Left-Sided Obstructive Heart Defects
por: Edwards, Jonathan J., et al.
Publicado: (2020)

Natriuretic Peptide Receptor-C Protects Against Angiotensin II-Mediated Sinoatrial Node Disease in Mice
por: Mackasey, Martin, et al.
Publicado: (2018)

Direct Interstitial Decongestion in an Animal Model of Acute-on-Chronic Ischemic Heart Failure
por: Abraham, William T., et al.
Publicado: (2021)

Heart Failure in Pulmonary Arterial Hypertension Is Just a WNK1 Away
por: Ha, Chae-Myeong, et al.
Publicado: (2021)

Improvement of Myocardial Function Following Catheter-Based Renal Denervation in Heart Failure
por: Liao, Song-Yan, et al.
Publicado: (2017)

SGLT2 Inhibitor–Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection
por: Herat, Lakshini Y., et al.
Publicado: (2020)

Trimming the Fat in HFpEF: Learning How to Target the Metabolic Disease Phenotype
por: Schilling, Joel D.
Publicado: (2020)

When Sensing Goes Wrong: Role of Clec4e in Ischemic Heart Injury
por: Delgobo, Murilo, et al.
Publicado: (2021)

Administration of a TLR9 Inhibitor Attenuates the Development and Progression of Heart Failure in Mice
por: Ueda, Hiromichi, et al.
Publicado: (2019)

Yes-Associated Protein (YAP) Facilitates Pressure Overload–Induced Dysfunction in the Diabetic Heart
por: Ikeda, Shohei, et al.
Publicado: (2019)

A Potential New Therapeutic Direction for Fibrosis in the Injured Heart Orchestrated by Cardiac MSCs
por: Cieslik, Katarzyna A.
Publicado: (2022)

Short-Term Administration of Serelaxin Produces Predominantly Vascular Benefits in the Angiotensin II/L-NAME Chronic Heart Failure Model
por: McCarthy, Joseph C., et al.
Publicado: (2017)

FYCO1 Regulates Cardiomyocyte Autophagy and Prevents Heart Failure Due to Pressure Overload In Vivo
por: Kuhn, Christian, et al.
Publicado: (2021)

Cardiomyocyte SMAD4-Dependent TGF-β Signaling is Essential to Maintain Adult Heart Homeostasis
por: Umbarkar, Prachi, et al.
Publicado: (2019)

Differential Effects of Sacubitril/Valsartan on Diastolic Function in Mice With Obesity-Related Metabolic Heart Disease
por: Croteau, Dominique, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9eviv6bbmtget0fq5g51k31202